Diabetic Foot Ulcer
Medizinische Erkrankungen
🦶
Endocrinology & Wound Care

Diabetic Foot Ulcer — Behandlung in Kuba

Diabetic foot ulcers are one of the most serious complications of diabetes, affecting approximately 15% of diabetic patients during their lifetime. Without proper treatment, they can lead to infection, gangrene, and amputation. Cuba has developed Heberprot-P®, a groundbreaking medication that has revolutionized diabetic foot ulcer treatment, significantly reducing amputation rates. At La Pradera International Health Center, our multidisciplinary diabetic foot clinic offers comprehensive care including Heberprot-P® therapy, advanced wound care, and limb salvage programs.

Letzte Aktualisierung: 2026-07 Geprüft von: La Pradera Diabetic Foot Clinic

Behandlungsvideo

Mehr über dieses Behandlungsprogramm erfahren

What Is a Diabetic Foot Ulcer?

A diabetic foot ulcer is an open sore or wound that occurs in approximately 15% of patients with diabetes, most commonly on the bottom of the foot. It develops due to a combination of factors including neuropathy (nerve damage), poor circulation, and high blood sugar levels that impair healing.

Neuropathic ulcers — caused by nerve damage, painless

Ischemic ulcers — caused by poor blood flow, painful

Neuro-ischemic ulcers — combination of both

Most common on pressure points of the foot

Can become infected without the patient feeling pain

Risk Factors and Prevention

Preventing diabetic foot ulcers is critical. Regular foot care and early intervention can prevent serious complications. Patients with diabetes should inspect their feet daily and seek immediate medical attention for any wound.

Daily foot inspection for cuts, blisters, or sores

Proper footwear and orthotic inserts

Regular podiatry visits

Blood sugar control (HbA1c management)

Smoking cessation — smoking impairs circulation

Regular vascular and neurological assessment

Prompt treatment of any foot wound

Heberprot-P®: Cuban Innovation

Heberprot-P® is a groundbreaking Cuban medication containing recombinant human epidermal growth factor (EGF), administered by intralesional injection directly into diabetic foot ulcers. Developed by the Center for Genetic Engineering and Biotechnology (CIGB) in Havana, it has been used to treat hundreds of thousands of patients worldwide, dramatically accelerating wound healing and reducing amputation rates.

Contains recombinant human epidermal growth factor (EGF)

Administered by intralesional injection into the wound

Accelerates granulation and wound healing

Significantly reduces amputation rates

Effective on chronic, non-healing ulcers

Used in over 30 countries worldwide

Advanced Wound Care Therapies

In addition to Heberprot-P®, our diabetic foot clinic offers a range of advanced wound care technologies to support healing and prevent complications.

Laser therapy for wound healing

Ozone therapy for infection control

Electrotherapy to stimulate tissue repair

Advanced wound dressings

Pressure offloading techniques

Surgical debridement when needed

Vascular Assessment and Circulation Support

Many diabetic foot ulcers are complicated by poor blood circulation. Our vascular assessment program evaluates blood flow to the lower extremities and provides treatments to improve circulation, which is essential for wound healing.

Non-invasive vascular screening (ankle-brachial index, Doppler)

Carotid and peripheral artery assessment

Cardiovascular risk profiling

Circulation support therapies

Coordination with vascular specialists if needed

Infection Management and Antibiotic Stewardship

Infection is a leading cause of amputation in diabetic foot ulcers. Our clinic follows evidence-based infection management protocols with responsible antibiotic use to treat infections while preventing antibiotic resistance.

Wound culture and sensitivity testing

Targeted antibiotic therapy

Regular wound monitoring and assessment

Surgical intervention for severe infections

Multidisciplinary approach with infectious disease specialists

Limb Salvage Program

Our limb salvage program is designed to prevent amputation whenever possible. Through a combination of advanced wound care, Heberprot-P®, vascular support, and surgical intervention when necessary, we help patients preserve their limbs and maintain mobility.

Comprehensive assessment of limb viability

Individualized treatment protocol

Multidisciplinary team approach

Surgical options including revascularization

Post-treatment rehabilitation and podiatry

Travel to Cuba for Diabetic Foot Treatment

Our international patient services team assists patients with all travel arrangements to Havana for diabetic foot treatment.

Medical treatment invitation letters

Airport reception and transportation

Accommodation for patient and family

Multilingual coordinators

Halal-certified meals and dietary accommodations

Coordination with your home physician

Beginnen Sie Ihre Reise zur Genesung

Senden Sie Ihre Krankenakte und Befunde, und unsere Spezialisten werden Ihren Fall prüfen und einen personalisierten Behandlungsplan empfehlen, der auf Ihre Bedürfnisse zugeschnitten ist.

Beratung AnfragenWhatsApp
Verwandtes Programm

Behandlung des Diabetischen Fußes

Das Behandlungsprogramm erkunden →

Diabetic Foot Ulcer — Häufig gestellte Fragen

Häufige Fragen internationaler Patienten zur Behandlung auf Kuba.

Heberprot-P® is a Cuban medication containing recombinant human epidermal growth factor (EGF). It is injected directly into diabetic foot ulcers to accelerate healing. It has been used to treat hundreds of thousands of patients and significantly reduces amputation rates.

Patientengeschichten: Diabetic Foot Ulcer

Wir verwenden Cookies, um Ihre Erfahrung zu verbessern und den Datenverkehr zu analysieren. Mit der Fortsetzung stimmen Sie unserer Verwendung von Cookies zu. Datenschutzerklärung